Integra Therapeutics vs Mammoth Biosciences
Integra Therapeutics vs Mammoth Biosciences, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Integra Therapeutics is on 54/100 and Mammoth Biosciences on 63/100.
Where each one leads
Integra Therapeutics
Leads on none of the measures we hold for both companies.
Mammoth Biosciences
- our overall score: 63/100 against 54/100
- agent readiness: 35/100 against 22/100
- domain rating: 53/100 against 25/100
- headcount: 165 against 24
- funding raised: $460M against $135M
- LinkedIn following: 57,986 against 6,180
At a glance
| Measure | Integra Therapeutics | Mammoth Biosciences |
|---|---|---|
| What it is | Biotech company developing next-generation gene writing tools for advanced therapies. | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. |
| Category | Biotech, Gene Therapy, Gene Editing, CAR-T | Biotechnology, Drug Discovery, Genomics, CRISPR Technology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2020 | 2017 |
| Headquarters | Barcelona, Spain | Brisbane, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Integra Therapeutics | Mammoth Biosciences |
|---|---|---|
| Employees | 24 | 165 |
| Headcount growthLast 12 months | Not published | +5.8% |
| Total funding | $135M | $460M |
| Latest round | Series A | Funding Round |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 6,180 | 57,986 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Integra Therapeutics | Mammoth Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 63/100 |
| Traction | 54/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | 15/100 | Not published |
| Search visibility | 22/100 | 35/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 53/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Integra Therapeutics | Mammoth Biosciences |
|---|---|---|
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Integra Therapeutics vs Mammoth Biosciences: common questions
Which is better, Integra Therapeutics or Mammoth Biosciences?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Integra Therapeutics and Mammoth Biosciences compare on the numbers?
Mammoth Biosciences leads on our overall score (63/100 against 54/100), agent readiness (35/100 against 22/100), domain rating (53/100 against 25/100), headcount (165 against 24), funding raised ($460M against $135M), LinkedIn following (57,986 against 6,180).
Read the full Integra Therapeutics review and pricing or the Mammoth Biosciences review and pricing. You can also browse other Integra Therapeutics alternatives we track.